Regado Biosciences says evaluating strategic alternatives
September 24, 2014 at 18:22 PM EDT
Sept 24 (Reuters) - Regado Biosciences Inc said it is evaluating a broad range of strategic alternatives, a month after the company terminated enrollment in a late-stage trial of its lead drug.